Home/Pipeline/Metformin API

Metformin API

Type 2 Diabetes

CommercialActive

Key Facts

Indication

Type 2 Diabetes

Phase

Commercial

Status

Active

Company

USV Biologics Division

About USV Biologics Division

Indian pharma company delivering generics and biosimilars with a strong API manufacturing base.

View full company profile

Therapeutic Areas

Diabetes Cardiovascular General Medicine

Other Type 2 Diabetes Drugs

Drug	Company	Phase	Status
Diabetes Management Gel	Gelteq Limited	Formulation Development	Active
Tolimidone	Biodexa Pharmaceuticals	Phase 2	Acquired Asset
Generic Semaglutide Injection (Obeda)	Dr. Reddy's Laboratories	Approved	Launched in India
BioChaperone® Lispro	Adocia	Phase 3	Active
BioChaperone® Combo (Insulin Glargine / Lixisenatide)	Adocia	Phase 2	Active
Empagliflozin	Azico Biophore	Commercial	Active
Sitagliptin Intermediate	AR Life Science	Commercial	Active
AJN003 (LuCI™)	AltrixBio	Pre-clinical	Advancing to Phase 1 (planned 2026)
Sitagliptin Phosphate Polymorph	Morepen Laboratories	Pre‑clinical	Active
Hepatic Denervation for Type 2 Diabetes	Metavention	Feasibility	Active
MVD-1 (SANA)	Eolo Pharma	Discovery	Active
Type 2 Diabetes Management	iWel	Development	Active